000 01518 a2200457 4500
005 20250515093331.0
264 0 _c20080527
008 200805s 0 0 eng d
022 _a1555-8576
024 7 _a10.4161/cbt.6.11.4832
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHonda, Hiroshi
245 0 0 _aRegulation of the CLDN3 gene in ovarian cancer cells.
_h[electronic resource]
260 _bCancer biology & therapy
_cNov 2007
300 _a1733-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650 0 4 _aAzacitidine
_xanalogs & derivatives
650 0 4 _aBinding Sites
650 0 4 _aCell Line, Tumor
650 0 4 _aClaudin-3
650 0 4 _aClaudin-4
650 0 4 _aCpG Islands
650 0 4 _aDNA Methylation
650 0 4 _aDecitabine
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aSp1 Transcription Factor
_xmetabolism
650 0 4 _aSp3 Transcription Factor
_xmetabolism
700 1 _aPazin, Michael J
700 1 _aD'Souza, Theresa
700 1 _aJi, Hongxiu
700 1 _aMorin, Patrice J
773 0 _tCancer biology & therapy
_gvol. 6
_gno. 11
_gp. 1733-42
856 4 0 _uhttps://doi.org/10.4161/cbt.6.11.4832
_zAvailable from publisher's website
999 _c17504721
_d17504721